CardioComm Solutions Inc. -- Year-End Update.VICTORIA, British Columbia--(BUSINESS WIRE)---Dec. 9, 1999-- (CDNX CDNX See Canadian Venture Exchange (CDNX). :CCG CCG Chicago CCG Collectible Card Game CCG Canadian Coast Guard CCG Country Commercial Guide CCG Children's Cancer Group CCG Commission Canadienne des Grains (Canadian Grain Commission) .) CardioComm Solutions Inc. (CDNX:CCG) (the "Company", "CardioComm") is pleased to provide an update on the following corporate developments: Marketing Strategy for 2000 The Company is planning an aggressive marketing strategy for North America and Europe in the year 2000 now that the regulatory requirements have been satisfied and the initial distributors have been engaged. Quality System and Product Certification CardioComm has received ISO (1) See ISO speed. (2) (International Organization for Standardization, Geneva, Switzerland, www.iso.ch) An organization that sets international standards, founded in 1946. The U.S. member body is ANSI. 9001 and EN 46001 Quality System recertifications by the auditors at TUV (Technischer Überwachungs-Verein) Literally "Technical Watch-Over Association." A German certifying body involved with product safety for the European community. Essen, part of one of the largest quality system certification bodies in the world. ISO 9001 and EN 46001 are the European equivalent of the US FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. Good Manufacturing Practice Good Manufacturing Practice or GMP (also referred to as 'cGMP' or 'current Good Manufacturing Practice') is a term that is recognized worldwide for the control and management of manufacturing and quality control testing of foods and pharmaceutical products. standards. In addition, the Company's Global ECG ECG electrocardiogram. ECG abbr. 1. electrocardiogram 2. electrocardiograph ECG Also called an electrocardiogram, it records the electrical activity of the heart. Management System(TM) (GEMS(TM)) qualified for the CE Mark which, along with ISO 9001 and EN 46001, are the required certifications for sale of product in Europe. The Company continues to work with its UK distributor and is negotiating with other potential distributors for the launch of GEMS(TM) in Europe in 2000. Software Installations The Company has recently sold and installed its software at Regina General Hospital in Saskatchewan and Kalamazoo Cardiology in Michigan. Regina General is a leading Canadian research institution. Kalamazoo Cardiology upgraded from a previous CardioComm product. In addition, due to customer requirements for database conversions and scheduling issues, the Company has a backlog of orders to be installed in January 2000. Exclusive Distribution Agreement Management has executed an exclusive Canadian distribution agreement with Baylis Medical Company Inc., a leading North American North American named after North America. North American blastomycosis see North American blastomycosis. North American cattle tick see boophilusannulatus. supplier of medical products to the fields of Cardiology and Electrophysiology. Baylis Medical specializes in the distribution of the premium products in each product category. The Company is aggressively targeting the Canadian market in 2000. Private Placement Pursuant to its news release dated September 22, 1999, the Company is pleased to confirm that it has received subscriptions for its private placement for 500,000 units at a price of $0.30 per unit for net proceeds of $150,000. The proceeds are being used for general working capital. Chief Software Architect In addition, management wishes to welcome the addition of Mr. Yves Duruisseau who has been retained as the Company's Chief Software Architect. Mr. Duruisseau has bachelor degrees in Science for Mathematics / Physics and Computer Science from University of Victoria. In 1989 he received the university gold medal for the highest standing for a graduating student in Science. CardioComm Solutions Inc. is a Canadian company dedicated to providing superior information technology to the field of Cardiology. CardioComm is committed to the containment of cardiovascular disease through improved information access, communication, management, and analysis. CardioComm's patented and proprietary technology is used in products for the recording, viewing, analyzing and storing of electrocardiograms (ECGs), for diagnosis and management of cardiac patients. CardioComm has achieved its technical goals of improved access and communication through the development of a real-time ECG viewer. CardioComm is the only company that provides a real-time means of viewing ECGs over a network (LAN (Local Area Network) A communications network that serves users within a confined geographical area. The "clients" are the user's workstations typically running Windows, although Mac and Linux clients are also used. , WAN or Internet). This tool enables ECGs to be viewed and controlled live, by physicians, over a global virtual healthcare network. This technology is packaged in CardioComm's initial software database product code named "Mercator" and marketed as Global ECG Management System(TM) (GEMS(TM)). GEMS(TM) was cleared for sale in the US by the FDA in January of 1999. For further information on the Company's hardware and software products please contact Mr. Stephen Martin at (250) 744-1822, EXT EXT Extension EXT Extended EXT External Ext Extraction EXT Exterior (screenwriting) EXT Extinguisher EXT Extruded EXT Extinguished EXT Exeter, England, United Kingdom - Exeter (Airport Code) 243 or visit the Company's website at www.cardiocomm.com On behalf of the Board of Directors of CardioComm Solutions Inc.: "Stephen Martin" Stephen R. Martin, President & CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. The Canadian Venture Exchange The Canadian Venture Exchange (CDNX) is now a defunct stock exchange having been acquired by the TSX Group in 2001 and renamed the TSX Venture Exchange. History of the Canadian Venture Exchange (CDNX) has not reviewed and does not accept responsibility for the adequacy or the accuracy of this release. CardioComm Solutions Inc. 771 Vanalman Avenue, Victoria, British Columbia, V8Z 3B8 Toll Free: 1-800-360-4809 Telephone: (250) 744-1822 Facsimile: (250) 744-1866 |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion